Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.

J.P. Morgan, Leerink Partners and Guggenheim Securities acted as joint book-running managers for the offering. LifeSci Capital acted as lead manager for the offering.

The Mintz corporate team included Members William Hicks, John Rudy and Alok Choksi and Associates Samantha Silver, Jocelyn Sun, and Brooke Siegal. Member Joanne Hawana provided regulatory advice, Member Ari Feder provided tax advice, and Associate Edmund Koundakjian, PhD provided intellectual property advice. Members of the Mintz team are based in the Boston, New York and San Diego offices.